Acino International AG - Company Profile
Powered by 
All the data and insights you need on Acino International AG in one report.
$295
- Save hours of research time and resources with
our up-to-date Acino International AG Strategy Report
- Understand Acino International AG position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Acino International AG’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Acino International AG's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
John Beighton
Chairman Executive BoardMr. John Beighton has been the Chairman since 2019. Prior to this, he was the Interim Chief Executive Officer of Zentiva. Mr. Beighton also served as the Chief Executive Officer of Mercury Pharma.
Steffen Saltofte
Chief Executive Officer Senior ManagementMr. Steffen Saltofte has been the Chief Executive Officer of the company since June 2018. Prior to this, he served as the Chief Operating Officer at Boehringer Ingelheim Animal Health and Merial. He also served as Managing Director at Syngenta.
Max Sorokin
Chief Financial Officer Senior ManagementMr. Max Sorokin has been the Chief Financial Officer of the company since June 2023. Prior to this, he served as the Acting Chief Financial Officer of the company. Previously, he served as the Head of Group Commercial Finance of the company since 2019.
Christina Peusch
Chief Legal and Compliance Officer Senior ManagementMs. Christina Peusch has been the Chief Legal and Compliance officer since 2015. Prior to this, she was the Head of Legal EUCAN (Europe/Canada), Emerging Markets and North Asia, Takeda Pharmaceuticals International GmbH. From 2004 to 2013, she held various senior posts in the field of Legal Affairs at Takeda Pharmaceuticals International GmbH, Nycomed Germany Holding GmbH and Altana Pharma AG. From 1995 to 2004, she was a member of the Commercial Law and Corporate Finance practice areas and Chief Representative of the Beijing office; Frankfurt am Main and Munich, Germany and Beijing, PRC.
Sarah Egan
Chief Human Resources Officer Senior ManagementMr. Sarah Egan is the Chief Human Resources Officer of the company. Prior to this, she has served as the Vice President of Human Resources in Roche; and in other leadership positions in Novartis.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer